VIR-2482
VIR-2482-3001
Phase 1 small_molecule completed
Quick answer
VIR-2482 for Influenza A is a Phase 1 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Influenza A
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed